EUVIMEDEUVIMED entdecken
Crossref

Engineered Neutrophil Nanovesicles for Inhibiting Corneal Neovascularization by Synergistic Anti‐Inflammatory, Anti‐VEGF, and Chemoexcited Photodynamic Therapy

Xiaoxue Liu, Yingxuan Bi, Chaoqun Wei, Ye Zhang, Xiaoyu Liu, Xinghan Guo, Longfei Zhao, Jingjing Zhang, Changlong Wang, Hua Gao iD

Advanced Materials · 2025-04 · 37 (14)

DOI: 10.1002/adma.202411030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 21.01.2025. Verfasst von Xiaoxue Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory Cultivation Base, Shandong Provincial Key Laboratory of Ophthalmology, Eye Institute of Shandong First Medical University, Qingd…. Hauptthemen laut MEDLINE: Photochemotherapy, Neutrophils, Corneal Neovascularization, Vascular Endothelial Growth Factor A. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Major Research Plan of the National Natural Science Foundation of Shandong Provincial, Youth Innovation Team Program of Colleges and Universities in Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Corneal neovascularization (CorNV) develops under various pathological conditions and is one of the main causes of blindness. Due to that CorNV progression involves multiple steps, anti‐vascular endothelial growth factor (VEGF) drugs alone could not sufficiently suppress this process, highlighting an urgent need for an efficient delivery system for the multi‐step management of CorNV. In this study, a neutrophil nanovesicle‐based eye drop (NCCR) is developed for CorNV therapy that simultaneously inhibits angiogenesis and inflammation, while eliminating pathological cells through chemoexcited photodynamic therapy (PDT). NCCR targets inflammatory lesions by leveraging the expression of chemokine receptors from the source cells. Then, NCCR exerts inhibitory effects on the sequential steps of neovascularization. First, it acts as a decoy and exerts an anti‐inflammatory effect by neutralizing cytokines via its receptors on the surface of nanovesicles. Second, thioketals bond‐linked ranibizumab is released in the high reactive oxygen species microenvironment of CorNV sites to bind VEGF, inhibiting vascular endothelial cell activation and proliferation. Finally, chemoexcited PDT eliminates preformed corneal blood vessels, disrupting tube formation and pericyte recruitment. The synergistic effects of NCCR on angiogenesis and inflammation, combined with the induction of apoptosis in neovessels via chemoexcited PDT, offer a novel and efficient strategy for CorNV treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyNeutrophilsCorneal NeovascularizationVascular Endothelial Growth Factor AAnti-Inflammatory AgentsAngiogenesis InhibitorsAnimalsHumansMiceRanibizumabReactive Oxygen SpeciesHuman Umbilical Vein Endothelial Cells

Stichwörter der Autor:innen

biomimetic nanomedicinechemoexcited photodynamic therapycorneal neovascularization therapyneutrophil nanovesicle‐based nanocarrier

Substanzen

Vascular Endothelial Growth Factor AAnti-Inflammatory AgentsAngiogenesis InhibitorsRanibizumabReactive Oxygen Species

Autor:innen und Institutionen

  • State Key Laboratory Cultivation Base, Shandong Provincial Key Laboratory of Ophthalmology, Eye Institute of Shandong First Medical University, Qingdao, 266071, China.
  • Eye Hospital of Shandong First Medical University, Jinan, 250021, China.
  • School of Ophthalmology, Shandong First Medical University & Shandong Academy of Medical Science, Jinan, 250000, China.
  • School of Life Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an, 271016, China.
  • Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, China.

ORCID-Profile: Hua Gao

Förderung

  • National Natural Science Foundation of China
  • Major Research Plan of the National Natural Science Foundation of Shandong Provincial
  • Youth Innovation Team Program of Colleges and Universities in Shandong Province
  • Talent Introduction Project of Shandong First Medical University
  • Taishan Scholar Foundation of Shandong Province
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Liu, X., Bi, Y., Wei, C., Zhang, Y., Liu, X., Guo, X., Zhao, L., Zhang, J., Wang, C., & Gao, H. (2025). Engineered Neutrophil Nanovesicles for Inhibiting Corneal Neovascularization by Synergistic Anti‐Inflammatory, Anti‐VEGF, and Chemoexcited Photodynamic Therapy. Advanced Materials, 37(14). https://doi.org/10.1002/adma.202411030

Vancouver

Liu X, Bi Y, Wei C, Zhang Y, Liu X, Guo X, et al. Engineered Neutrophil Nanovesicles for Inhibiting Corneal Neovascularization by Synergistic Anti‐Inflammatory, Anti‐VEGF, and Chemoexcited Photodynamic Therapy. Advanced Materials. 2025;37(14). doi:10.1002/adma.202411030

BibTeX
@article{Liu2025,
  author = {Liu, Xiaoxue and Bi, Yingxuan and Wei, Chaoqun and Zhang, Ye and Liu, Xiaoyu and Guo, Xinghan and Zhao, Longfei and Zhang, Jingjing and Wang, Changlong and Gao, Hua},
  title = {Engineered Neutrophil Nanovesicles for Inhibiting Corneal Neovascularization by Synergistic Anti‐Inflammatory, Anti‐VEGF, and Chemoexcited Photodynamic Therapy},
  journal = {Advanced Materials},
  year = {2025},
  volume = {37},
  number = {14},
  doi = {10.1002/adma.202411030}
}
Kostenlos starten →